Alamar Biosciences Announces First Five Distribution Partners, Expanding Commercial Support in Asia Pacific
FREMONT, Calif., March 19, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce the signing of five new distribution partners to expand its global presence. The company has partnered with established industry leaders across key international markets to enhance access to its innovative proteomics technologies. ...
Patricia Industries’ subsidiary Advanced Instruments to acquire and merge with Nova Biomedical
NORWOOD, Mass., March 19, 2025 /PRNewswire/ -- Patricia Industries' subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, today announced the execution of a definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients...
Jacobio Pharma Announces 2024 Annual Results
BEIJING, SHANGHAI and BOSTON, March 19, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) released its 2024 annual results, with revenue of RMB160 million, R&D expense of RMB330 million. Major operating and financing activities generated RMB320 million cash inflows. By the end of 2024, cash and bank balances and bank credit balances amounted to RMB1.45 billion. Jacobio also announced recent business progress...
Sisram Medical Announces 2024 Annual Results
New product launches drive double-digit growth in key markets and deliver market outperformance amid economic challenges HONG KONG, March 19, 2025 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, featuring a distinguished synergistic ecosystem of business building blocks and consumer-focused approaches including Energy-Based Devices...
Terumo Neuro Celebrates 15 Years of the WEB™ Device: A Game-Changing Innovation in Aneurysm Treatment
More than 25,000 Devices Implanted Worldwide from 2010-20251 ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of the groundbreaking WEB™ Aneurysm Embolization System. Since its introduction, the WEB device has transformed...
Lynx Analytics Unveils LynxKite 2000:MM – The Next Generation of GPU-Optimized Graph AI
LOS GATOS, Calif., March 19, 2025 /PRNewswire/ -- Lynx Analytics, a member of the NVIDIA Inception program for startups, today announced the launch of LynxKite 2000:MM, the most advanced version of its Graph AI platform. Designed to accelerate Graph AI and Generative AI applications, this major release is optimized for NVIDIA accelerated computing,...
“Miracle Doctor” Dr. Wei-Hua Chen: Role of Oligo Fucoidan in Cancer Care
LOS ANGELES, March 19, 2025 /PRNewswire/ -- Dr. Wei-Hua Chen, a renowned 70-year-old cardiologist and the director of Hongxin Clinic (Taichung, Taiwan), has been awarded the "28th Fervent Global Love of Lives Award 2025" by the Chou Ta-Kuan Cultural and Educational Foundation. First diagnosed with cancer at the age of 32, he had battled four different types of cancer over...
Siemens Applauded by Frost & Sullivan for Supporting the Evolution of Smart Hospitals and Its Market-leading Position
Siemens strengthens its leadership position in the healthcare sector with its competency in digitalizing facilities and operations, thus enabling the progression of smart hospitals. SAN ANTONIO, March 19, 2025 /PRNewswire/ -- Frost & Sullivan recently researched the smart building solutions for the healthcare industry and, based on its findings, recognizes Siemens with the 2024 Global Company of the Year...
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
IRVINE, Calif., March 19, 2025 /PRNewswire/ -- Zymo Research Corporation acknowledges the recent ruling, on March 14, 2025, by the United States District Court for the Central District of California in the ongoing litigation with QIAGEN GmbH. The Court has denied QIAGEN's Partial Motion to Dismiss and, in the alternative, to stay...
Launched at Breakthrough 2025, ArisGlobal announces LifeSphere Unify, NavaX Insights, and Advanced Compliance Docs
ZURICH, March 19, 2025 /PRNewswire/ -- ArisGlobal, a leading life sciences technology company and creator of LifeSphere®, today announced three new cutting-edge product offerings that will advance pharmacovigilance and regulatory operations. At Breakthrough 2025, its annual industry event, the company unveiled LifeSphere Unify, NavaX Insights, and Advanced Compliance Docs. LifeSphere Unify -...
